Layer 1
Cma

Refine

E.g., 19/09/2021
E.g., 19/09/2021

Refine

Refine

E.g., 19/09/2021
E.g., 19/09/2021

cma

Advanz Pharma and Cinven told C+D they will appeal the CMA’s decision
The outcome of a Competition and Markets Authority’s (CMA) investigation, published today (July 29), found that Advanz charged an excessive price for...
29/07/2021 3
CMA: The cost of one pack of 10mg hydrocortisone tablets rose from 70p in 2008 to £88 by 2016
The Competition and Markets Authority (CMA) issued fines yesterday (July 15) totalling more than £260 million to “several pharmaceutical firms” for...
16/07/2021 8
Alexion Pharmaceuticals manufactures medicines to treat rare diseases
The watchdog is considering if the proposed £27.6 billion ($39bn) merger “may be expected to result in a substantial lessening of competition within...
02/06/2021 0
The pharmaceutical companies had appealed the Competition and Markets Authority’s (CMA) 2016 findings that they had broken competition law, but the...
11/05/2021 1
Lexon was accused, along with two other wholesalers, of colluding to keep nortriptyline prices up
Through an investigation carried out last year, the Competition and Markets Authority (CMA) concluded that King Pharmaceuticals, Auden Mckenzie,...
25/02/2021 0
RPS: Concerns remain about the future pricing of Priadel
In a letter to the Competition and Markets Authority (CMA) last week (December 11), the Royal Pharmaceutical Society (RPS) and charity the College of...
16/12/2020 0
The newly agreed prices are still lower than alternative bipolar drugs on the market
Priadel 200mg will cost £7.50 per pack, while the 400mg version will be priced at £8.50 under the agreement. These prices are “still lower than...
25/11/2020 2
Essential Pharma has said Priadel is loss-making in the UK market.
The CMA has opened an investigation into the manufacturer for “suspected anti-competitive practices in the supply of drugs used to treat bipolar...
07/10/2020 4
CMA: The companies colluded to keep the price of life-saving Addison’s disease treatment high
Aspen has been fined £2,101,954 and Tiofarma £186,442 for breaking competition law to keep the price of fludrocortisone acetate 0.1 mg...
09/07/2020 3
A “small minority” of pharmacies are seeking to profit from the pandemic, the GPhC and CMA said
A letter from the General Pharmaceutical Council (GPhC) and the Competition and Markets Authority (CMA) yesterday (June 29) said they had received...
30/06/2020 8

Pages